Overview

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Status:
Completed
Trial end date:
2006-06-01
Target enrollment:
Participant gender:
Summary
This trial will assess any efficacious benefit and any safety issues associated with the concomitant use of olanzapine and carbamazepine for the treatment of patients with bipolar I disorder, manic or mixed episodes
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Carbamazepine
Olanzapine